Techno Medical PCL (BKK:TM)
Thailand · Delayed Price · Currency is THB 1.200
-0.040 (-3.23%)
Sep 3, 2026, 4:36 PM ICT
Techno Medical PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 716.96 | 705.16 | 725.18 | 696.02 | 642.86 | 674.15 |
Other Revenue | 3.08 | 0.93 | 0.54 | 0.99 | 2.18 | 1.3 |
| 720.04 | 706.09 | 725.72 | 697.01 | 645.04 | 675.45 | |
Revenue Growth | 0.41% | -2.71% | 4.12% | 8.06% | -4.50% | 6.94% |
Cost of Revenue | 452.65 | 454.87 | 494.39 | 465.5 | 414.33 | 418.31 |
Gross Profit | 267.4 | 251.22 | 231.33 | 231.51 | 230.71 | 257.13 |
Selling, General & Admin | 214.85 | 205.48 | 227.09 | 225.24 | 212.3 | 201.81 |
Operating Expenses | 216.61 | 205.49 | 227.46 | 224.63 | 212.15 | 202.01 |
Operating Income | 50.79 | 45.73 | 3.87 | 6.88 | 18.56 | 55.12 |
Interest Expense | -11.42 | -13.32 | -19.97 | -15.58 | -6.27 | -5.02 |
Interest & Investment Income | 0.49 | 0.3 | 0.29 | - | - | - |
Currency Exchange Gain (Loss) | -0.8 | 1.49 | 4.44 | 5.66 | 4.69 | -4.91 |
EBT Excluding Unusual Items | 39.05 | 34.19 | -11.36 | -3.05 | 16.97 | 45.19 |
Asset Writedown | - | - | -14.94 | - | - | - |
Pretax Income | 39.05 | 34.19 | -26.3 | -3.05 | 16.97 | 45.19 |
Income Tax Expense | 13.46 | 12.12 | 4.83 | 8.88 | 5.89 | 15.45 |
Earnings From Continuing Operations | 25.59 | 22.07 | -31.14 | -11.92 | 11.08 | 29.74 |
Minority Interest in Earnings | 5.1 | 5.45 | 9.5 | 7.44 | 1.91 | 0.76 |
Net Income | 30.69 | 27.51 | -21.64 | -4.49 | 12.99 | 30.5 |
Net Income to Common | 30.69 | 27.51 | -21.64 | -4.49 | 12.99 | 30.5 |
Net Income Growth | 586.00% | - | - | - | -57.41% | -25.74% |
Shares Outstanding (Basic) | 308 | 308 | 308 | 308 | 308 | 308 |
Shares Outstanding (Diluted) | 308 | 308 | 308 | 308 | 314 | 308 |
Shares Change | - | - | - | -1.94% | 1.98% | -0.27% |
EPS (Basic) | 0.10 | 0.09 | -0.07 | -0.01 | 0.04 | 0.10 |
EPS (Diluted) | 0.10 | 0.09 | -0.07 | -0.01 | 0.04 | 0.10 |
EPS Growth | 586.90% | - | - | - | -58.18% | -25.56% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 425.77 | 438.24 | 454.01 | -71.97 | -110.37 | -48.65 |
Free Cash Flow Per Share | 1.38 | 1.42 | 1.47 | -0.23 | -0.35 | -0.16 |
Dividend Per Share | - | - | - | 0.033 | 0.050 | 0.085 |
Dividend Growth | - | - | - | -34.00% | -41.18% | -15.00% |
Gross Margin | 37.14% | 35.58% | 31.88% | 33.21% | 35.77% | 38.07% |
Operating Margin | 7.05% | 6.48% | 0.53% | 0.99% | 2.88% | 8.16% |
Profit Margin | 4.26% | 3.90% | -2.98% | -0.64% | 2.01% | 4.52% |
Free Cash Flow Margin | 59.13% | 62.07% | 62.56% | -10.32% | -17.11% | -7.20% |
EBITDA | 76.79 | 74.89 | 36.29 | 34.2 | 34.41 | 68.79 |
EBITDA Margin | 10.66% | 10.61% | 5.00% | 4.91% | 5.33% | 10.18% |
D&A For EBITDA | 26 | 29.17 | 32.42 | 27.32 | 15.85 | 13.67 |
EBIT | 50.79 | 45.73 | 3.87 | 6.88 | 18.56 | 55.12 |
EBIT Margin | 7.05% | 6.48% | 0.53% | 0.99% | 2.88% | 8.16% |
Effective Tax Rate | 34.47% | 35.45% | - | - | 34.70% | 34.19% |
Revenue as Reported | 721.54 | 707.58 | 730.16 | 702.67 | 649.73 | 670.54 |